OSI PHARMACEUTICALS, INC. AMENDED AND RESTATED STOCK INCENTIVE PLAN RESTRICTED STOCK AGREEMENTRestricted Stock Agreement • July 12th, 2006 • Osi Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
Contract Type FiledJuly 12th, 2006 Company Industry JurisdictionTHIS RESTRICTED STOCK AGREEMENT (the “Agreement”) is made this 14th day of July, 2006 (the “Grant Date”) by and between OSI PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and [DIRECTOR] (the “Director”).
OSI PHARMACEUTICALS, INC. AMENDED AND RESTATED STOCK INCENTIVE PLAN RESTRICTED STOCK UNIT AGREEMENTRestricted Stock Unit Agreement • July 12th, 2006 • Osi Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
Contract Type FiledJuly 12th, 2006 Company Industry JurisdictionTHIS RESTRICTED STOCK UNIT AGREEMENT (the “Agreement”) is made this 14th day of July, 2006 (the “Grant Date”) by and between OSI PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and [EXECUTIVE OFFICER] (the “Employee”). Capitalized terms, unless otherwise defined herein, shall have their respective meanings as set forth in the OSI Pharmaceutical, Inc. Amended and Restated Stock Incentive Plan (the “Plan”).
OSI PHARMACEUTICALS, INC. AMENDED AND RESTATED STOCK INCENTIVE PLAN RESTRICTED STOCK AGREEMENTRestricted Stock Agreement • July 12th, 2006 • Osi Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
Contract Type FiledJuly 12th, 2006 Company Industry JurisdictionTHIS RESTRICTED STOCK AGREEMENT (the “Agreement”) is made this 14th day of July, 2006 (the “Grant Date”) by and between OSI PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and [EXECUTIVE OFFICER] (the “Employee”).
OSI PHARMACEUTICALS, INC. AMENDED AND RESTATED STOCK INCENTIVE PLAN RESTRICTED STOCK UNIT AGREEMENTRestricted Stock Unit Agreement • July 12th, 2006 • Osi Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
Contract Type FiledJuly 12th, 2006 Company Industry JurisdictionTHIS RESTRICTED STOCK UNIT AGREEMENT (the “Agreement”) is made this 14th day of July, 2006 (the “Grant Date”) by and between OSI PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and [DIRECTOR] (the “Director”). Capitalized terms, unless otherwise defined herein, shall have their respective meanings as set forth in the OSI Pharmaceutical, Inc. Amended and Restated Stock Incentive Plan (the “Plan”).